إعلان
إعلان

PMVP

PMVP logo

PMV Pharmaceuticals, Inc

1.18
USD
برعاية
0.00
-0.42%
٠٩ يناير, ١٥:٣٦ UTC -5
مغلق
exchange

قبل الإفتتاح

1.21

+0.03
+2.12%

تقارير أرباح PMVP

النسبة الإيجابية المفاجئة

PMVP تفوق 12 من 20 آخر التقديرات.

60%

التقرير التالي

بيانات التقرير القادم
٠٢ مارس ٢٠٢٦
Estimate for Q4 25 (Revenue/ EPS)
--
/
-$0.41
التغير الضمني من Q3 25 (Revenue/ EPS)
--
/
+2.50%
التغير الضمني من Q4 24 (Revenue/ EPS)
--
/
-8.89%

PMV Pharmaceuticals, Inc earnings per share and revenue

On ١٢ نوفمبر ٢٠٢٥, PMVP reported earnings of -0.40 USD per share (EPS) for Q3 25, beating the estimate of -0.41 USD, resulting in a 2.58% surprise. Revenue reached --, compared to an expected --, with a 0.00% difference. The market reacted with a +6.77% price change (close before vs. close after earnings).
Looking ahead to Q4 25, 6 المحللين forecast an EPS of -0.41 USD, with revenue projected to reach -- USD, implying an زيادة of 2.50% EPS, and زيادة of 0.00% in Revenue from the last quarter.
الأسئلة الشائعة
For Q3 2025, PMV Pharmaceuticals, Inc reported EPS of -$0.40, beating estimates by 2.58%, and revenue of $0.00, 0% as expectations.
The stock price moved up 6.77%, changed from $1.33 before the earnings release to $1.42 the day after.
The next earning report is scheduled for ٠٢ مارس ٢٠٢٦.
Based on 6 المحللين, PMV Pharmaceuticals, Inc is expected to report EPS of -$0.41 and revenue of -- for Q4 2025.
شيك FXEmpire's Earnings Calendar for today's list of reporting companies.
إعلان